GlaxoSmithKline May Settle 1,000 More Avandia Lawsuits, Attorney Says

Published: May 05, 2011

GlaxoSmithKline Plc, after setting aside more than $6 billion to help settle lawsuits over medicines including its Avandia diabetes drug, is poised to resolve 1,000 more cases, a lawyer for patients said.

Glaxo, the U.K.’s biggest drugmaker, is in settlement talks with lawyers for an estimated 1,000 former Avandia users who sued the company in state courts in Pennsylvania, California and Illinois, Dianne Nast, a plaintiffs’ attorney who serves on a group helping to oversee cases consolidated in federal court in Philadelphia, said in an interview yesterday.

“There are a total of about 5,300 state-court cases pending” around the country, Nast told U.S. District Judge Cynthia Rufe at a hearing in Philadelphia. “I expect a multiple number of them probably will be resolved.” After the hearing, Nast declined to comment on the amount of any settlements.

Back to news